Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Lilly

Status and phase: Completed; Phase 3

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: insulin lispro injection [rDNA origin] Low Mix

Study type: Interventional

Funder types: Industry

Identifiers

NCT00231725

H9D-MC-ITAB

9673

Details and patient eligibility

About

Trial of new insulin injection pen called Pre-filled Pen B by type 2 diabetics in take home situations. Patients must use insulin lispro injection [rDNA origin] Low Mix twice daily during the trial.

Sex: All

Ages: 25 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 Diabetes
• Already on Lilly insulin or beginning insulin therapy
• 25 to 75 years old inclusive

Exclusion criteria

• Currently using, or had used during previous month, oral diabetes medication that is NOT approved for use in combination with insulin in patient's country
• More than 3 unexplained episodes of severe hypoglycemia within 6 months prior to trial